Drug intelligence / Profile preview

Noma

Development stage
Unknown
Lead developer
Sam-A Pharm
Modality
Small Molecules
Administration
Oral
01

Overview

Noma is a prominent line of pediatric nutritional supplements developed and marketed by the South Korean company Sam-A Pharmaceutical. The product series is specifically formulated to meet the nutritional requirements of growing children and infants, providing a balanced combination of essential vitamins and minerals. The Noma product line includes various formulations such as Noma Gold and Noma F, which are typically available as chewable tablets or granules to enhance pediatric compliance. These supplements contain a comprehensive blend of nutrients, including Vitamin A, B-complex (B1, B2, B6, B12), C, D, and E, along with minerals such as calcium and magnesium. Noma is indicated for the prevention and treatment of vitamin and mineral deficiencies, supporting bone development, immune function, and overall physical growth in the pediatric population.

Brand names
NomaNoma GoldNoma FNoma ChewableNoma KidsKiddymin
Other names
Sam-A children's vitaminchildren's vitamin-Sam-A PharmaceuticalNoma-F
02

Targets

RARA (Retinoic acid receptor alpha)RARG (Retinoic acid receptor gamma)RARB (Retinoic acid receptor beta)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Noma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Noma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call